383 related articles for article (PubMed ID: 33393074)
21. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).
Chalmers JR; Schmitt J; Apfelbacher C; Dohil M; Eichenfield LF; Simpson EL; Singh J; Spuls P; Thomas KS; Admani S; Aoki V; Ardeleanu M; Barbarot S; Berger T; Bergman JN; Block J; Borok N; Burton T; Chamlin SL; Deckert S; DeKlotz CC; Graff LB; Hanifin JM; Hebert AA; Humphreys R; Katoh N; Kisa RM; Margolis DJ; Merhand S; Minnillo R; Mizutani H; Nankervis H; Ohya Y; Rodgers P; Schram ME; Stalder JF; Svensson A; Takaoka R; Teper A; Tom WL; von Kobyletzki L; Weisshaar E; Zelt S; Williams HC
Br J Dermatol; 2014 Dec; 171(6):1318-25. PubMed ID: 24980543
[TBL] [Abstract][Full Text] [Related]
22. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
24. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
[TBL] [Abstract][Full Text] [Related]
25. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
[TBL] [Abstract][Full Text] [Related]
26. Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review.
Heinl D; Prinsen CA; Drucker AM; Ofenloch R; Humphreys R; Sach T; Flohr C; Apfelbacher C
Syst Rev; 2016 Feb; 5():25. PubMed ID: 26860189
[TBL] [Abstract][Full Text] [Related]
27. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
[TBL] [Abstract][Full Text] [Related]
28. Measurement properties of patient-reported outcome measures for eczema control: a systematic review.
Stuart BL; Howells L; Pattinson RL; Chalmers JR; Grindlay D; Rogers NK; Grinich E; Pawlitschek T; Simpson EL; Thomas KS
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):1987-1993. PubMed ID: 33977561
[TBL] [Abstract][Full Text] [Related]
29. Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials.
Penton H; Jayade S; Selveindran S; Heisen M; Piketty C; Ulianov L; Jabbar-Lopez ZK; Silverberg JI; Puelles J
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2549-2571. PubMed ID: 37747670
[TBL] [Abstract][Full Text] [Related]
30. Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review.
Heinl D; Chalmers J; Nankervis H; Apfelbacher CJ
Acta Derm Venereol; 2016 Jun; 96(5):596-601. PubMed ID: 26676847
[TBL] [Abstract][Full Text] [Related]
31. Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.
Heinl D; Prinsen CAC; Sach T; Drucker AM; Ofenloch R; Flohr C; Apfelbacher C
Br J Dermatol; 2017 Apr; 176(4):878-889. PubMed ID: 27543747
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema.
Chinn DJ; Poyner T; Sibley G
Br J Dermatol; 2002 Mar; 146(3):432-9. PubMed ID: 11952543
[TBL] [Abstract][Full Text] [Related]
33. Measuring Signs of Atopic Dermatitis in Clinical Practice: A HOME-CP Consensus Statement.
Jacobson ME; Leshem YA; Apfelbacher C; Spuls PI; Gerbens LAA; Thomas KS; Williams HC; Katoh N; Howells L; Schmitt J; Deckert S; Seshadri R; Simpson EL;
JAMA Dermatol; 2024 May; ():. PubMed ID: 38776110
[TBL] [Abstract][Full Text] [Related]
34. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial.
Thomas KS; Bradshaw LE; Sach TH; Cowdell F; Batchelor JM; Lawton S; Harrison EF; Haines RH; Ahmed A; Dean T; Burrows NP; Pollock I; Buckley HK; Williams HC; Llewellyn J; Crang C; Grundy JD; Guiness J; Gribbin A; Wake EV; Mitchell EJ; Brown SJ; Montgomery AA
Health Technol Assess; 2017 Apr; 21(16):1-260. PubMed ID: 28409557
[TBL] [Abstract][Full Text] [Related]
35. Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review.
Gerbens LA; Chalmers JR; Rogers NK; Nankervis H; Spuls PI;
Br J Dermatol; 2016 Oct; 175(4):678-86. PubMed ID: 27012805
[TBL] [Abstract][Full Text] [Related]
36. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
[TBL] [Abstract][Full Text] [Related]
37. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults.
Ring J; Zink A; Arents BWM; Seitz IA; Mensing U; Schielein MC; Wettemann N; de Carlo G; Fink-Wagner A
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1331-1340. PubMed ID: 31002197
[TBL] [Abstract][Full Text] [Related]
38. [Not Available].
Lacour JP
Ann Dermatol Venereol; 2020 Nov; 147(11S1):11S12-11S18. PubMed ID: 33250133
[TBL] [Abstract][Full Text] [Related]
39. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).
Howells LM; Chalmers JR; Gran S; Ahmed A; Apfelbacher C; Burton T; Howie L; Lawton S; Ridd MJ; Rogers NK; Sears AV; Spuls P; von Kobyletzki L; Thomas KS
Br J Dermatol; 2020 Sep; 183(3):524-536. PubMed ID: 31794074
[TBL] [Abstract][Full Text] [Related]
40. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.
Heinl D; Prinsen CA; Deckert S; Chalmers JR; Drucker AM; Ofenloch R; Humphreys R; Sach T; Chamlin SL; Schmitt J; Apfelbacher C
Allergy; 2016 Mar; 71(3):358-70. PubMed ID: 26564008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
